What did the Multimodal Treatment of Attention Deficit Hyperactivity (MTA) study find?
The Multimodal Treatment of Attention Deficit Hyperactivity Disorder study was designed to analyze the leading treatments of ADHD that included drug therapy, in-depth behavior therapy, or a consolidation of the two. There was an initial 14-month study and a 6 to 8 year follow-up (Molina et al., 2011). The ages of the children that were studied initially were 7 to about 10 years old. One of the findings that the initial 14 month study indicated was that the kind of treatment, (medication, behavior therapy, community care or, combinations of treatment), did not forecast how the children would be behaving 6 to 8 years later, but could be used as an assumption of what kind of behavior might be displayed going into adolescence (Molina et al., 2011). The combination of medication and behavioral therapy, rather than behavioral only or, community care only, indicated the best type of progress for the participants of the initial 14-month study (Molina et al., 2011).
The study revealed 3 sets of conclusions; there were no marked distinctions among the children of the random group at 7 to 9 years of age; the symptom path as a child gave a prediction of the outcome at the 6 and 8 year follow-up; even with the medication and the behavioral therapy the MTA group was at a lower capacity of functioning than the non-MTA sample at 2 years. What the study showed was that the disparity of the effects of treatment at the time of delivery lessened when the treatment was relaxed (Molina et al., 2011). The introductory clinical appearance of ADHD in childhood that included the worst of ADHD symptoms, any conduct problems, the intellect of the child, any social superiority, and the child’s symptom response, was a better prognosis of later adolescent behavior than what treatment was received in childhood for the initial 14 month study (Molina et al., 2011).
Another revelation of the study was that of math accomplishment. The children that were continuing to take meds by 6 and 8 years were no better off than the non-medicated ones. The MTA study did support the usage of medication for the reduction of intense symptoms at the start but did not support long-term gains beyond 2 years for most children.
The MTA study acknowledged the need for long term monitoring because of the variations in symptoms and the need for community services between the MTA children and their non-ADHD peers into adolescence so, the MTA...